Related Experiment Videos
Improved prediction of the minimal phototoxic dose in PUVA therapy
A Sakuntabhai1, J N Matthews, P M Farr
1Department of Dermatology, Royal Victoria Infirmary, Newcastle upon Tyne, U.K.
Abstract:
In an attempt to improve the prediction of PUVA erythemal sensitivity, we have examined, in 251 patients, the relationship between the minimal phototoxic dose (MPD) and a number of variables, including skin type, ingested dose of 8-methoxypsoralen (8-MOP) and history of previous PUVA treatment. The MPD was determined by phototesting 2 h after ingestion of crystalline 8-MOP, given at a standard dose of 0.6 mg/kg (calculated to the nearest 10 mg). No reaction to the highest dose of UVA used for phototesting occurred in 16% of cases; the dose of 8-MOP was significantly associated with non-response. In the patients in whom an erythemal response was obtained, a significant association was found between the MPD and the variables of skin type, ingested dose of 8-MOP, and history of previous PUVA treatment. Thus, by taking these factors into account, a more accurate prediction can be made of an individual patient's erythemal sensitivity to PUVA than relying on skin type alone. That erythemal sensitivity is affected by the ingested dose of 8-MOP (even when all patients received 0.6 mg/kg) suggests that conventional psoralen dosing according to body weight is not ideal.
Insights
Predicting PUVA erythemal sensitivity is improved by considering skin type, 8-methoxypsoralen (8-MOP) dose, and prior PUVA treatment. These factors offer a more accurate assessment than skin type alone.
Area of Science:
- Dermatology
- Photobiology
- Pharmacology
Background:
- Photochemotherapy using psoralens and UVA (PUVA) is a common dermatological treatment.
- Accurate prediction of individual erythemal sensitivity to PUVA is crucial for treatment efficacy and safety.
- Current prediction methods, often relying solely on skin type, may not be sufficiently precise.
Purpose of the Study:
- To investigate factors influencing minimal phototoxic dose (MPD) in PUVA therapy.
- To develop a more accurate method for predicting PUVA erythemal sensitivity.
- To assess the impact of 8-methoxypsoralen (8-MOP) dosage and patient history on treatment response.
Main Methods:
- Studied 251 patients undergoing PUVA therapy.
- Determined MPD via phototesting 2 hours after ingesting a standard 0.6 mg/kg dose of 8-MOP.
- Collected data on skin type, ingested 8-MOP dose, and previous PUVA treatment history.
Main Results:
- 16% of patients showed no erythemal response to the highest UVA dose; 8-MOP dose was linked to non-response.
- In responding patients, MPD significantly correlated with skin type, ingested 8-MOP dose, and prior PUVA treatment.
- These variables collectively improved erythemal sensitivity prediction compared to skin type alone.
Conclusions:
- Combining skin type, 8-MOP dose, and treatment history enhances PUVA erythemal sensitivity prediction.
- Standard body-weight-based psoralen dosing may not be optimal, as individual sensitivity varies.
- Personalized prediction models are essential for optimizing PUVA therapy outcomes.